NWPF

News ArchivesRead News

Search For Parkinson's Genes Turns To Online Social Networking

Monday August 20, 2012

NPR - There's a growing interest in what our genes say about our health. And in recent years, quite a few companies have sprung up to help us listen with the help of personalized DNA tests.

For a few hundred dollars and a vial of spit, these companies will search your DNA for sequences that predict your physical traits, your response to certain drugs and your risk for any number of diseases.

One such company, California-based 23andMe, is attempting to use the data to do something different: search for new genes linked to Parkinson's disease. The company, which calls itself the world's first genetics-based social network, has collected more than 125,000 DNA samples from customers.

Most customers likely wanted to find out more about their personal genetic risks — not to contribute to medical science. But in 2009, the company decided to do genetic research, and it invited anyone diagnosed with Parkinson's disease to donate their DNA sample.


23andMe recruited people online using social media, and at Parkinson's research conferences. In exchange for participating, they're offered the company's personalized genetics services free. Participants provided a DNA sample and answered questions about their diagnosis, symptoms and lifestyle habits in online surveys.

"They may in theory be able to involve 10,000 people with Parkinson's disease, and do it cheaply and easily," explains Hank Greely, a Stanford Law School professor who follows genetics companies. "Now that's something that academic researchers would love to be able to do."

In the past, researchers looked at families with many members who had the disease, allowing them to zero in on single genes that would dramatically increase a person's risk of getting Parkinson's. But of the million or so people in the U.S. with Parkinson's disease, less than 10 percent have any of the genes discovered so far.

Researchers think that's because there are many genes involved in Parkinson's — but that their effects are too small to be seen in just a few hundred to a few thousand people. Emily Drabant, research director at 23andMe, hopes that by looking at many thousands of people, they may be able to find them.


Shots - Health Blog
Grappling With The Uncertainty Of Alzheimer's Testing
"We know that there are many genes, so the idea is when you aggregate across many thousands of people you can start to see genes that have perhaps a small effect on risk for Parkinson's," she says. "Perhaps, you have three or four risk variants and the combination increases your risk for Parkinson's quite significantly."

But observers like Greely say a dose of skepticism is in order. He wonders if 23andMe's customers will truly be representative of the population, and if the subjects can be trusted to accurately report their diagnosis and symptoms.


Health
Say 'Ahhh': A Simpler Way To Detect Parkinson's
Criticism of direct-to-consumer genetics companies is nothing new. Many have questioned the ethics of delivering genetic information directly to the consumer, as well as the value and the accuracy of the genetic risks they report.

23andMe is now seeking FDA approval for its genetic testing kits. The company submitted applications for seven health-related tests so far and plans to include more than 100 more in the coming months.

When it comes to research, many also wonder if these companies will have incentives to report positive findings too soon. But Robert Green of Harvard Medical School says that companies with large profit incentives have been doing medical research for years, and while skepticism is in order, the controversial nature of these companies is not a reason to entirely discredit their approach to research.

"You know social media has changed the rest of our lives – there's no reason why social media and the Internet can't revolutionize some aspects of medical research as well," he says. "I see this as part of a larger trend, not something that's really restricted to genetic testing companies."

23andMe has had considerable success. Though short of its goal, the company has discovered two new genes. Drabant says they have also been able to uncover rare combinations of mutated genes associated with Parkinson's that no one had found before.

Drabant says she recognizes an Internet-based approach to genetics research makes many scientists uncomfortable. It's something new. But she also says she believes companies like 23andMe have the power to make important genetic discoveries faster, and cheaper than has been done in the past. Given enough time and research subjects, she hopes to prove it.

http://www.npr.org/blogs/health/2012/08/20/158943097/search-for-parkinsons-genes-turns-to-online-social-networking?f=1128&ft=1&sc=tw

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression